Cargando…
Clozapine Reverses Dysfunction of Glutamatergic Neurons Derived From Clozapine-Responsive Schizophrenia Patients
The cellular pathology of schizophrenia and the potential of antipsychotics to target underlying neuronal dysfunctions are still largely unknown. We employed glutamatergic neurons derived from induced pluripotent stem cells (iPSC) obtained from schizophrenia patients with known histories of response...
Autores principales: | Hribkova, Hana, Svoboda, Ondrej, Bartecku, Elis, Zelinkova, Jana, Horinkova, Jana, Lacinova, Lubica, Piskacek, Martin, Lipovy, Bretislav, Provaznik, Ivo, Glover, Joel C., Kasparek, Tomas, Sun, Yuh-Man |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904748/ https://www.ncbi.nlm.nih.gov/pubmed/35281293 http://dx.doi.org/10.3389/fncel.2022.830757 |
Ejemplares similares
-
Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
por: Goldstein, Meghan Elizabeth, et al.
Publicado: (2015) -
Derivation and Molecular Characterization of a Morphological Subpopulation of Human iPSC Astrocytes Reveal a Potential Role in Schizophrenia and Clozapine Response
por: Akkouh, Ibrahim A, et al.
Publicado: (2021) -
Corrigendum to: Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
Publicado: (2023) -
Peripheral Inflammatory Markers in Subtypes and Core Features of Depression: A Systematized Review
por: Křenek, Pavel, et al.
Publicado: (2023) -
Cardiac sequelae after COVID-19: Results of a 1-year follow-up study with echocardiography and biomarkers
por: Matejova, Gabriela, et al.
Publicado: (2022)